Welcome to our dedicated page for Qualtrics International news (Ticker: XM), a resource for investors and traders seeking the latest updates and insights on Qualtrics International stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Qualtrics International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Qualtrics International's position in the market.
Qualtrics has announced the pricing of its initial public offering (IPO) of 51,695,568 shares of Class A common stock at $30.00 per share. The shares will begin trading on the Nasdaq under the ticker symbol XM today, with the offering closing on February 1, 2021. In addition, there’s a 30-day option for underwriters to buy up to 7,754,335 additional shares at the IPO price. Morgan Stanley and J.P. Morgan are the lead managers for this offering.